Elevated baseline D-dimer plasma levels are associated with a prompt response to omalizumab in patients with severe CSU.
暂无分享，去创建一个
[1] Janko Brand,et al. Serum autoreactivity predicts time to response to omalizumab therapy in chronic spontaneous urticaria. , 2017, The Journal of allergy and clinical immunology.
[2] S. Ferrucci,et al. D-Dimer Plasma Levels Parallel the Clinical Response to Omalizumab in Patients with Severe Chronic Spontaneous Urticaria , 2017, International Archives of Allergy and Immunology.
[3] R. Asero. Plasma D-dimer levels and clinical response to ciclosporin in severe chronic spontaneous urticaria. , 2015, The Journal of allergy and clinical immunology.
[4] R. Asero. D-dimer: a biomarker for antihistamine-resistant chronic urticaria. , 2013, The Journal of allergy and clinical immunology.
[5] M. Shima,et al. Increase of coagulation potential in chronic spontaneous urticaria , 2011, Allergy.
[6] F. Wang,et al. Activation of the blood coagulation cascade is involved in patients with chronic urticaria. , 2009, The Journal of allergy and clinical immunology.
[7] R. Asero,et al. Severe chronic urticaria is associated with elevated plasma levels of D‐dimer , 2007, Allergy.
[8] D. Fanoni,et al. Activation of the tissue factor pathway of blood coagulation in patients with chronic urticaria. , 2007, The Journal of allergy and clinical immunology.
[9] J. Kochan,et al. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. , 1993, The New England journal of medicine.